Luteinising hormone-releasing hormone analogue reverses the cell adhesion profile of EGFR overexpressing DU-145 human prostate carcinoma subline

Cetrorelix, a luteinising hormone-releasing hormone (LHRH) analogue, has been shown to limit growth of the human androgen-independent prostate cell line DU-145, although other inhibitory actions may also be affected. Both growth and invasion of DU-145 cells are linked to autocrine epidermal growth f...

Descripción completa

Detalles Bibliográficos
Autores principales: Yates, C, Wells, A, Turner, T
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2005
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361841/
https://www.ncbi.nlm.nih.gov/pubmed/15655536
http://dx.doi.org/10.1038/sj.bjc.6602350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361841/
https://www.ncbi.nlm.nih.gov/pubmed/15655536
http://dx.doi.org/10.1038/sj.bjc.6602350

Ejemplares similares